Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median
Ther Adv Med Oncol. 2020 Jun 3:12:1758835920930643.
doi: 10.1177/1758835920930643.
eCollection 2020.